NEUROTOL-M 10ML India - English - Central Drugs Standard Control Organization

neurotol-m 10ml

venus rem. - mannitol - 10ml

NEUROTOL Tablets 200 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

neurotol tablets 200 milligram

clonmel healthcare ltd - tablets - 200 milligram

NEUROTOL SYRUP Ireland - English - HPRA (Health Products Regulatory Authority)

neurotol syrup

clonmel healthcare ltd - 100/5 milligram

NEUROTOL 10 OD CAP India - English - Central Drugs Standard Control Organization

neurotol 10 od cap

l & v ph. - methylcobalamin,silymarin - od cap - 1500mcg,140mg - 10

NEUROTOL 100/300;ML INF India - English - Central Drugs Standard Control Organization

neurotol 100/300;ml inf

venus rem. - glycerin,mannitol - inf - 10,10;% - 100/300;ml

Medtronic NIM-Neuro 3.0 System Singapore - English - HSA (Health Sciences Authority)

medtronic nim-neuro 3.0 system

medtronic international, ltd. - general hospital - intended for locating and identifying cranial and peripheral motor and mixed motor-sensory nerves during surgery, including spinal cord and spinal nerve roots. the aps™electrode is an accessory intended for providing automatic periodic stimulation to nerves when used with the medtronic nerve monitoring systems.

Medtronic NIM-Pulse 3.0 System and Accessories Singapore - English - HSA (Health Sciences Authority)

medtronic nim-pulse 3.0 system and accessories

medtronic international, ltd. - anaesthesiology - the nim 3.0 is intended for locating and identifying cranial and peripheral motor and mixed motor-sensory nerves during surgery, including spinal cord and spinal nerve roots.

MULTIHANCE SOLUTION Canada - English - Health Canada

multihance solution

bracco imaging canada - gadobenate dimeglumine - solution - 529mg - gadobenate dimeglumine 529mg - other diagnostic agents

VIMPAT lacosamide 200 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

vimpat lacosamide 200 mg film-coated tablets blister pack

ucb australia pty ltd t/a ucb pharma division of ucb australia - lacosamide, quantity: 200 mg - tablet, film coated - excipient ingredients: hyprolose; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - vimpat (lacosamide) tablets and oral solution are indicated as:,? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.,? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.,? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

VIMPAT lacosamide 150 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

vimpat lacosamide 150 mg film-coated tablets blister pack

ucb australia pty ltd t/a ucb pharma division of ucb australia - lacosamide, quantity: 150 mg - tablet, film coated - excipient ingredients: hyprolose; microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - vimpat (lacosamide) tablets and oral solution are indicated as:,? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.,? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older.,? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.